Immune Evasion and Resistance in Cancer Progression: Overcoming Checkpoint Inhibition Challenges with Personalized Immunotherapy Guided by PD-L1 Expression. J. Anal. Oncol. 2025;14:49-61. doi:10.30683/1927-7229.2025.14.09